Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
Prediction Markets
Private Markets
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Hikma Pharmaceuticals PLC Stock News

HKMPYOTCPK

Trade with Public

Trade with Public

$37.30

At close: Apr 21, 5:00 PM EST

OverviewNewsShort Interest

Latest Hikma Pharma Stock News | OTC:HKMPY | Benzinga

Get the latest news on Hikma Pharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Hikma Pharma performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, September 06, 2024

Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
Vandana Singh

Wednesday, August 28, 2024

Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices
Vandana Singh

Monday, June 12, 2023

Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
Vandana Singh

Tuesday, March 31, 2020

Amarin Shares Drop 67% As Court Invalidates Its Heart Drug Patent For Vascepa
Neer Varshney

Tuesday, December 10, 2019

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin

Thursday, April 06, 2017

UBS Likes The Tune Of Jazz Pharma's Settlement With Hikma
Benzinga

Monday, March 20, 2017

Jazz Pharma Gives Shorts A Wake-Up Call After JZP-110 Study Results
Benzinga
Leerink Presents: Your 2017 Biopharma Catalyst Tracker
Benzinga

Wednesday, February 10, 2016

Hikma Pharmaceuticals Offering $535M Less than Earlier Offer to Acquire Boehringer Ingelheim's US Generic Drug Business
Benzinga

Wednesday, March 11, 2015

Hikma Pharmaceuticals 2014 Profit Surges
Benzinga

Wednesday, November 20, 2013

Hikma Signs Long Term Supply Agreement With Unilife To Enhance Delivery Of Generic Injectables
Benzinga

Wednesday, March 13, 2013

Hikma Pharma Full-Year Profit Rises 19%
Benzinga

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved

Comments

Loading...